⌘K

Login Start Free

Home/Insiders/Dube Michael P

DM

SEC Insider//CIK 0002019493

Dube Michael P

CIK 00020194931 companyCAMBRIDGE, MA

Transactions

8

Companies

1

Filings

8

CIK

0002019493

Recent Transactions

8 trades

Award
Intellia Therapeutics, Inc.$NTLA
Common Stock
2026-03-01+17,250→ 69,527 total
Sale
Intellia Therapeutics, Inc.$NTLA
Common Stock
2026-01-05$9.21/sh−2,989→ 52,277 total
Sale
Intellia Therapeutics, Inc.$NTLA
Common Stock
2025-10-01$17.38/sh−1,871→ 55,266 total
Sale
Intellia Therapeutics, Inc.$NTLA
Common Stock
2025-07-02$9.95/sh−2,503→ 57,137 total
Award
Intellia Therapeutics, Inc.$NTLA
Common Stock
2025-03-01+14,000→ 59,640 total
Sale
Intellia Therapeutics, Inc.$NTLA
Common Stock
2025-01-03$12.18/sh−1,372→ 45,640 total
Sale
Intellia Therapeutics, Inc.$NTLA
Common Stock
2024-10-02$19.01/sh−2,012→ 47,012 total
Award
Intellia Therapeutics, Inc.$NTLA
Common Stock
2024-07-01+17,801→ 49,024 total

Companies

1

Intellia Therapeutics, Inc.
VP, Chief Accounting Officer
$NTLA

Recent Filings

8

Address

C/O INTELLIA THERAPEUTICS, INC. 40 ERIE STREET; SUITE 130

CAMBRIDGE, MA, 02139

View on SEC.gov